Interleukin 15 Levels in Serum May Predict a Severe Disease Course in Patients with Early Arthritis

Evidence for treating rheumatoid arthritis to target: results of a systematic literature search

(2010) M. Schoels et al.   ANNALS OF THE RHEUMATIC DISEASES

A rational use of glucocorticoids in patients with early arthritis has a minimal impact on bone mass

(2010) Monica Ibañez et al.   ARTHRITIS RESEARCH & THERAPY

Does gene expression analysis inform us in rheumatoid arthritis?

(2009) T Haupl et al.   ANNALS OF THE RHEUMATIC DISEASES

Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe

(2009) P Emery et al.   ANNALS OF THE RHEUMATIC DISEASES

Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis

(2009) Péter Szodoray et al.   AUTOIMMUNITY REVIEWS

Predicting the development of RA in patients with early undifferentiated arthritis

(2009) Karim Raza et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Inhibition of tumour necrosis factor and IL-17 production by leflunomide involves the JAK/STAT pathway

(2008) I Gonzalez-Alvaro et al.   ANNALS OF THE RHEUMATIC DISEASES

Progression of joint damage in early rheumatoid arthritis: Association with HLA–DRB1, rheumatoid factor, and anti–citrullinated protein antibodies in relation to different treatment strategies

(2008) J. K. de Vries-Bouwstra et al.   ARTHRITIS AND RHEUMATISM

Biologic therapy for early rheumatoid arthritis: the latest evidence

(2008) Hernan Castro-Rueda et al.   CURRENT OPINION IN RHEUMATOLOGY

Signalling, inflammation and arthritis: Crossed signals: the role of interleukin-15 and -18 in autoimmunity

(2008) H. P. Carroll et al.   RHEUMATOLOGY

The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?

(2008) Josef S Smolen et al.   ARTHRITIS RESEARCH & THERAPY